Trump announces trade deal with EU following months of negotiations
Andreas P. Wagner, the Chief Human Resources Officer at Alignment Healthcare (NASDAQ:ALHC), recently executed a series of stock sales totaling $207,733. These transactions took place over two days, on March 18 and 19, 2025. The sales come as ALHC trades near its 52-week high of $17.27, having delivered an impressive 259% return over the past year and currently commanding a market capitalization of $3.3 billion. Wagner sold a total of 12,520 shares of common stock at prices ranging from $16.088 to $16.9588 per share.
The sales were conducted to cover tax withholding obligations related to the vesting of restricted stock units and immediately vested common stock, as noted in the filings. Following these transactions, Wagner retains ownership of 223,474 shares in the company.
In other recent news, Alignment Healthcare has reported impressive fourth-quarter 2024 earnings, surpassing analysts’ expectations. The company achieved an EPS of -0.16, better than the forecasted -0.18, and its revenue reached $701.2 million, exceeding the expected $674.97 million. Piper Sandler and Raymond (NSE:RYMD) James have both raised their price targets for Alignment Healthcare, to $21 and $19, respectively, reflecting confidence in the company’s growth trajectory. Piper Sandler maintained an Overweight rating, while Raymond James reiterated a Strong Buy rating, citing robust membership growth and improved financial metrics.
Alignment Healthcare’s membership grew by approximately 59%, and the company achieved its first year of adjusted EBITDA profitability. For 2025, the company has issued guidance projecting revenue between $3.72 billion and $3.78 billion, with adjusted gross profit expected to range from $415 million to $445 million. Additionally, the company anticipates health plan membership to grow to between 227,000 and 233,000 members by the end of the year. Analysts from Piper Sandler highlighted the company’s strategic approach, emphasizing its scalable and repeatable processes that enhance clinical outcomes and control costs.
Raymond James analyst John Ransom noted Alignment Healthcare’s ability to leverage its clinical model and operational scale to drive annual growth of 20% or more. The company’s strategies have been particularly effective in expanding beyond California, with notable membership growth in states like Nevada and North Carolina. These developments suggest a promising outlook for Alignment Healthcare as it continues to expand its market presence and enhance its financial performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.